CrossBridge Bio raised $10M in seed financing led by TMC Venture Fund and CE-Ventures to advance the development of next-generation dual-payload ADC therapies.
Amount Raised
$10 Million
Round Type
Seed
HoustonBiotechnologyHealth CareTherapeuticsInvestors
Description
CrossBridge Bio, a biotechnology company, has secured $10 million in seed financing. The funds will support the development of their lead program and expand their pipeline of novel ADC programs targeting cancer therapies.
Quick answer
CrossBridge Bio raised $10 Million in a Seed round, dated November 4, 2024. Investors: Linden Lake Labs, Ce Ventures, TMC Venture Fund, Portal Innovations and Alexandria Venture Investments. CrossBridge Bio is based in Houston, Texas, United States.
- How much did CrossBridge Bio raise?
- CrossBridge Bio raised $10 Million in a Seed round on November 4, 2024.
- Who invested in CrossBridge Bio?
- Linden Lake Labs, Ce Ventures, TMC Venture Fund, Portal Innovations and Alexandria Venture Investments are named as investors in this round.
- What does CrossBridge Bio do?
- CrossBridge Bio is pioneering an approach to deliver the next generation of stable antibody-drug conjugates (ADC) therapeutics that carry dual payloads as targeted treatments for a range of challenging cancers.
- Where is CrossBridge Bio based and how big is it?
- CrossBridge Bio is based in Houston, Texas, United States. Fundz records about 5 employees.
- Who are the decision-makers at CrossBridge Bio?
- Fundz holds 1 contact at CrossBridge Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as CrossBridge Bio that raised within 45 days of this round, from Fundz verified event records.
- Borealis Biosciences raised $30M (Series A) on December 19, 2024.
- Akamis Bio raised $60M (Series A) on December 17, 2024.
- Promise Bio raised $8.3M (Seed) on December 16, 2024.
- BioSapien raised $5.5M (Series A) on December 13, 2024.
- East Ocyon Bio raised $4.2M (Seed) on December 11, 2024.
- Noema Pharma raised $147M (Series B) on December 11, 2024.
Who to call at CrossBridge Bio, and when
A new round usually means CrossBridge Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CrossBridge Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CrossBridge Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CrossBridge Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CrossBridge Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CrossBridge Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.